A detailed history of Sg Americas Securities, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 12,759 shares of INVA stock, worth $241,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,759
Previous 81,500 84.34%
Holding current value
$241,145
Previous $1.34 Million 81.6%
% of portfolio
0.0%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$16.33 - $20.04 $1.12 Million - $1.38 Million
-68,741 Reduced 84.34%
12,759 $246,000
Q2 2024

Jul 12, 2024

BUY
$14.4 - $16.4 $1.04 Million - $1.19 Million
72,418 Added 797.38%
81,500 $1.34 Million
Q1 2024

May 06, 2024

BUY
$14.56 - $16.78 $132,233 - $152,395
9,082 New
9,082 $138,000
Q3 2023

Oct 13, 2023

BUY
$12.37 - $13.89 $250,467 - $281,244
20,248 Added 159.53%
32,940 $428,000
Q2 2023

Jul 10, 2023

SELL
$11.39 - $13.72 $239,896 - $288,970
-21,062 Reduced 62.4%
12,692 $162,000
Q1 2023

Apr 28, 2023

SELL
$10.73 - $13.6 $170,328 - $215,886
-15,874 Reduced 31.99%
33,754 $380,000
Q4 2022

Feb 02, 2023

BUY
$11.8 - $13.78 $585,610 - $683,873
49,628 New
49,628 $658,000
Q2 2022

Jul 29, 2022

SELL
$14.32 - $19.88 $26,134 - $36,281
-1,825 Reduced 2.63%
67,608 $998,000
Q1 2022

Apr 29, 2022

BUY
$15.39 - $20.25 $1.07 Million - $1.41 Million
69,433 New
69,433 $1.34 Million
Q4 2021

Feb 07, 2022

SELL
$15.91 - $18.72 $1.54 Million - $1.81 Million
-96,495 Closed
0 $0
Q3 2021

Nov 01, 2021

SELL
$13.06 - $17.24 $23,037 - $30,411
-1,764 Reduced 1.8%
96,495 $1.61 Million
Q2 2021

Aug 12, 2021

BUY
$11.45 - $13.96 $512,730 - $625,128
44,780 Added 83.73%
98,259 $1.32 Million
Q1 2021

May 13, 2021

BUY
$11.06 - $12.87 $319,335 - $371,595
28,873 Added 117.34%
53,479 $639,000
Q4 2020

Feb 04, 2021

BUY
$9.33 - $12.48 $229,573 - $307,082
24,606 New
24,606 $305,000
Q2 2020

Jul 20, 2020

SELL
$11.49 - $15.26 $8.77 Million - $11.6 Million
-763,123 Closed
0 $0
Q1 2020

Apr 30, 2020

BUY
$8.11 - $15.23 $4.29 Million - $8.06 Million
529,349 Added 226.44%
763,123 $8.97 Million
Q4 2019

Jan 28, 2020

SELL
$10.28 - $14.38 $56,303 - $78,759
-5,477 Reduced 2.29%
233,774 $3.31 Million
Q3 2019

Nov 04, 2019

BUY
$10.05 - $14.55 $589,512 - $853,473
58,658 Added 32.48%
239,251 $2.52 Million
Q2 2019

Jul 29, 2019

BUY
$13.1 - $14.95 $1.29 Million - $1.48 Million
98,770 Added 120.71%
180,593 $2.63 Million
Q1 2019

Apr 29, 2019

SELL
$13.69 - $20.06 $2.97 Million - $4.35 Million
-216,623 Reduced 72.58%
81,823 $1.15 Million
Q4 2018

Feb 01, 2019

BUY
$13.96 - $18.26 $4.17 Million - $5.45 Million
298,446 New
298,446 $5.21 Million
Q3 2018

Nov 06, 2018

SELL
$13.63 - $15.7 $193,218 - $222,563
-14,176 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$13.44 - $17.59 $99,617 - $130,377
7,412 Added 109.58%
14,176 $196,000
Q1 2018

May 03, 2018

BUY
$13.8 - $16.99 $93,343 - $114,920
6,764 New
6,764 $113,000
Q4 2017

Jan 24, 2018

SELL
$11.73 - $14.75 $242,060 - $304,381
-20,636 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$12.06 - $14.12 $248,870 - $291,380
20,636
20,636 $291,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.32B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.